SAVLON ANTISEPTIC LIQUID. %v/v Cutaneous Solution Concentrate

Land: Irland

Språk: engelska

Källa: HPRA (Health Products Regulatory Authority)

Köp det nu

Ladda ner Bipacksedel (PIL)
11-06-2024
Ladda ner Produktens egenskaper (SPC)
11-06-2024

Aktiva substanser:

CETRIMONIUM BROMIDE CHLORHEXIDINE GLUCONATE

Tillgänglig från:

Novartis Consumer Health UK Limited

INN (International namn):

CETRIMONIUM BROMIDE CHLORHEXIDINE GLUCONATE

Dos:

%v/v

Läkemedelsform:

Cutaneous Solution Concentrate

Receptbelagda typ:

Product not subject to medical prescription

Bemyndigande status:

Authorised

Tillstånd datum:

0000-00-00

Bipacksedel

                                250ML
_Antiseptic Liquid_
DIRECTIONS: DO NOT USE UNDILUTED ON THE SKIN.
FOR FIRST AID TREATMENT 
add 2 capfuls (30ml) of the liquid 
Gently apply the diluted 
to 
1
/
2
 litre of warm water
liquid to the affected area
FOR PERSONAL HYGIENE 
add 2 capfuls (30ml) of the liquid 
 to 
1
/
2
 litre of warm water
• Keep out of eyes, ears and other mucosa • Treat accidental
splashes into the eyes by washing 
open eyes with water for at least 10 minutes • Do not use if you are
allergic to any of the 
ingredients • Benzyl benzoate maybe mildly irritant to the skin,
eyes and mucous membranes • If 
skin irritation occurs, stop using and seek medical advice • If
swallowed, wash out mouth, drink 
plenty of milk or water. Seek medical advice and show this container
to a doctor • If symptoms 
persist or allergic reaction occurs, discontinue use and seek medical
advice. • Keep out of the 
reach and sight of children.
SAVLON ANTISEPTIC LIQUID gently cleanses and helps prevent
infection, 
aiding in the natural healing of minor skin injuries. Savlon
Antiseptic Liquid 
may also be used in bathing to help cleanse the skin.
CAUTION: FOR EXTERNAL USE ONLY
ACTIVE INGREDIENTS: Cetrimide 2.25% w/v and Chlorhexidine Gluconate
0.225% w/v. 
Also contains: Isopropyl alcohol, terpineol, liquid deodoriser, benzyl
benzoate, 
d-gluconolactone, sodium hydroxide and purified water. 
Do not store above 25ºC. Do not use Savlon Antiseptic Liquid
after the expiry date which is stated
on the bottom of the bottle. 
Date of information: August 2013
Savlon is a registered trade mark.
PA Holder and manufacturer: PA 30/28/1
Novartis Consumer Health, 
Horsham, RH12 5AB, UK
Manufacturer: BCM Limited,
Nottingham, NG90 2PR, UK
FOR BATHING 
add 5 capfuls (75ml) to bath water
.FOR FULL BENEFIT DO NOT MIX 
WITH SOAP OR DETERGENT
N TV
X
0
MM
1 0
2 0
3 0
4 0
5 0
6 0
7 0
8 0
9 0
100
110
120
130
140
150
160
170
180
190
200
210
220
230
240
250
260
270
280
CUSTOMER: Novartis   CUSTOMER REF: NXTV0    ARA NO: 112
                                
                                Läs hela dokumentet
                                
                            

Produktens egenskaper

                                SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Savlon Antiseptic Liquid.
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Cetrimide 2.25 % w/v and Chlorhexidine Gluconate 0.225 % w/v.
Excipients: also includes benzyl benzoate 0.056% w/v
For a full list excipients, see Section 6.1.
3 PHARMACEUTICAL FORM
Concentrate for Cutaneous Solution.
A clear, colourless or almost colourless liquid with a pine-like odour.
4 CLINICAL PARTICULARS
4.1 THERAPEUTIC INDICATIONS
A topical antiseptic for prevention and management of infection or superficial skin trauma.
4.2 POSOLOGY AND METHOD OF ADMINISTRATION
For cutaneous use.
Two capfuls to ½ litre of warm water.
4.3 CONTRAINDICATIONS
Hypersensitivity to chlorhexidine, cetrimide or to any of the excipients listed in Section 6.1.
4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE
If symptoms persist or condition worsens or if a skin reaction occurs, discontinue use and consult a doctor.
For external use only.
Avoid contact with the eyes, ears, mouth or other mucosa.
If accidentally splashed into the eye, the open eye should be irrigated with water for at least 10 minutes.
Savlon Antiseptic Liquid contains benzyl benzoate which may be mildly irritant to the skin, eyes and mucous
membranes.
4.5 INTERACTION WITH OTHER MEDICINAL PRODUCTS AND OTHER FORMS OF INTERACTION
No interaction studies have been performed with the topical forms.
IRISH MEDICINES BOARD
________________________________________________________________________________________________________________________
_Date Printed 09/09/2013_
_CRN 2119982_
_page number: 1_
4.6 FERTILITY, PREGNANCY AND LACTATION
PREGNANCY
There are no adequate data from the use of chlorhexidine and cetrimide in pregnant women. The potential risk for
humans is unknown but is most likely very low since chlorhexidine and cetrim
                                
                                Läs hela dokumentet